We are live on ! Find out more
WTA

Washington Trust Advisors Portfolio holdings

AUM $1.24B
1-Year Est. Return 22.58%
This Fund
S&P 500
This Quarter Est. Return
+7.64%
1 Year Est. Return
+22.58%
3 Year Est. Return
+71.21%
5 Year Est. Return
10 Year Est. Return
AUM
$1.03B
AUM Growth
+$49.1M
Cap. Flow
-$9.34M
Cap. Flow %
-0.91%
Top 10 Hldgs %
36.09%
Holding
791
New
12
Increased
93
Reduced
247
Closed
132

Top Buys

Rank Stock Value
1
CHWY icon
Chewy
CHWY
+$4.96M
2
MSGE icon
Madison Square Garden
MSGE
+$2.89M
3
APTV icon
Aptiv
APTV
+$2.27M
4
SPHR icon
Sphere Entertainment
SPHR
+$1.43M
5
UBER icon
Uber
UBER
+$489K

Top Sells

Rank Stock Value
1
PWR icon
Quanta Services
PWR
+$3.7M
2
AAPL icon
Apple
AAPL
+$2.07M
3
PANW icon
Palo Alto Networks
PANW
+$1.46M
4
META icon
Meta Platforms (Facebook)
META
+$1.09M
5
NVDA icon
NVIDIA
NVDA
+$1.03M

Sector Composition

Rank Sector Weight
1 Technology 18.21%
2 Healthcare 16.72%
3 Industrials 12.58%
4 Consumer Discretionary 11.94%
5 Communication Services 10.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMRC
626
Commerce.com Inc Series 1
CMRC
$264M
$2K ﹤0.01%
201
LSXMK
627
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$1.89K ﹤0.01%
75
-515
-87% -$11.5K
ALKT icon
628
Alkami Technology
ALKT
$1.94B
$1.87K ﹤0.01%
114
NYC
629
American Strategic Investment Co
NYC
$25.7M
$1.77K ﹤0.01%
+224
New +$2.03K
IXUS icon
630
iShares Core MSCI Total International Stock ETF
IXUS
$57.4B
$1.75K ﹤0.01%
28
FIGS icon
631
FIGS
FIGS
$1.73B
$1.61K ﹤0.01%
195
RPAY icon
632
Repay Holdings
RPAY
$344M
$1.61K ﹤0.01%
205
CYTK icon
633
Cytokinetics
CYTK
$10.8B
$1.6K ﹤0.01%
49
PCVX icon
634
Vaxcyte
PCVX
$7.88B
$1.6K ﹤0.01%
32
MRUS
635
DELISTED
Merus
MRUS
$1.58K ﹤0.01%
60
QTWO icon
636
Q2 Holdings
QTWO
$3.71B
$1.58K ﹤0.01%
51
FWONA icon
637
Liberty Media Series A
FWONA
$23.3B
$1.56K ﹤0.01%
24
-24
-50% -$1.52K
NVRO
638
DELISTED
NEVRO CORP.
NVRO
$1.55K ﹤0.01%
61
FITB
639
Fifth Third Bancorp
FITB
$52.4B
$1.47K ﹤0.01%
56
-169
-75% -$4.36K
DYN icon
640
Dyne Therapeutics
DYN
$4.28B
$1.41K ﹤0.01%
125
MRTX
641
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$1.37K ﹤0.01%
38
CGEM icon
642
Cullinan Oncology
CGEM
$1.07B
$1.37K ﹤0.01%
127
+56
+79% +$595
KURA icon
643
Kura Oncology
KURA
$826M
$1.22K ﹤0.01%
115
CYRX icon
644
CryoPort
CYRX
$765M
$1.21K ﹤0.01%
70
PTRA
645
DELISTED
Proterra Inc. Common Stock
PTRA
$1.19K ﹤0.01%
992
PLRX icon
646
Pliant Therapeutics
PLRX
$66.3M
$1.18K ﹤0.01%
65
AGGY icon
647
WisdomTree Yield Enhanced US Aggregate Bond Fund
AGGY
$925M
$992 ﹤0.01%
23
ALEC icon
648
Alector
ALEC
$169M
$938 ﹤0.01%
156
STRO icon
649
Sutro Biopharma
STRO
$393M
$833 ﹤0.01%
18
TWST icon
650
Twist Bioscience
TWST
$5.51B
$655 ﹤0.01%
32

Similar funds

Washington Trust Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Washington Trust Advisors held 791 positions worth $1.03B, up 5% from $982M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Washington Trust Advisors's Q2 2023 filing shows 12 new, 93 increased, 247 reduced and 132 closed positions. Its largest new stake was Madison Square Garden: 84,181 shares worth $2.83M. The largest sale was Quanta Services, an estimated $3.7M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.

  • Washington Trust Advisors's largest Q2 2023 buy was Madison Square Garden: 84,181 shares worth $2.83M.
  • Washington Trust Advisors added most to Chewy in Q2 2023, an estimated $4.96M increase.
  • Washington Trust Advisors's biggest Q2 2023 reduction was Quanta Services, cutting an estimated $3.7M.
  • Washington Trust Advisors fully exited Coinbase in Q2 2023, selling an estimated $549K.
  • Washington Trust Advisors's ten largest holdings make up 36% of its $1.03B portfolio in Q2 2023.
  • Washington Trust Advisors opened 12 new positions and closed 132 in Q2 2023.
  • Washington Trust Advisors's portfolio value rose 5% quarter-over-quarter to $1.03B.

Based on Washington Trust Advisors's 13F filing for Q2 2023, filed 27 Jul 2023.